Dylan V. Miller
No Rating Available
(Learn About Our Rating System)

Dylan V. Miller, MD

Languages spoken: English

  • Dr. Dylan Miller's specialty expertise includes cardiovascular and renal pathology, with an interest in cardiac transplantation pathology, vasculitis syndromes, aortopathies, and immune-mediated diseases.

    Specialties

    • Pathology, Anatomical

    Board Certification

    American Board of Pathology (Anatomic & Clinical)

  • Dr. Dylan Miller's specialty expertise includes cardiovascular and renal pathology, with an interest in cardiac transplantation pathology, vasculitis syndromes, aortopathies, and immune-mediated diseases.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Anatomic & Clinical)

    Education history

    Fellowship Surgical Pathology Fellowship Program - Mayo School of Graduate Medical Education, College of Medicine, Mayo Clinic Fellow
    Pediatric Pathology Externship (One Month Rotation) - Primary Children’s Medical Center Externship
    Chief Resident Anatomic and Clinical Pathology Residency Program - Department of Laboratory Medicine and Pathology, Mayo Graduate School of Medicine Chief Resident
    Leadership and Management Training Course - Department of Laboratory Medicine and Pathology Certificate
    Residency Anatomic and Clinical Pathology Residency Program - Mayo School of Graduate Medical Education, College of Medicine, Mayo Clinic Resident
    Medicine - University of Utah School of Medicine M.D.
    Undergraduate Microbiology - Brigham Young University B.S.

    Selected Publications

    Journal Article

    1. Austin AL, Broaddus RR, Souers RJ, Kane ME, Kolhe R, Miller DV, Moncur JT, Ramkissoon S, Tafe LJ, Trembath DG, Graham RP (2024). Current laboratory testing practices for mismatch repair deficiency and microsatellite instability testing: A survey-based review of current laboratory practices. Am J Clin Pathol. (Read full article)
    2. Bhargava R, Esposito NN, OConnor SM, Li Z, Turner BM, Moisini I, Ranade A, Harris RP, Miller DV, Li X, Moosavi H, Clark BZ, Brufsky AM, Dabbs DJ (2020). Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study. Mod Pathol, 34(1), 77-84. (Read full article)
    3. Duong Van Huyen JP, Fedrigo M, Fishbein GA, Leone O, Neil D, Marboe C, Peyster E, von der Thsen J, Loupy A, Mengel M, Revelo MP, Adam B, Bruneval P, Angelini A, Miller DV, Berry GJ (2020). The XVth Banff Conference on Allograft Pathology the Banff Workshop Heart Report: Improving the diagnostic yield from endomyocardial biopsies and Quilty effect revisited. Am J Transplant, 20(12), 3308-3318. (Read full article)
    4. Borowsky AD, Glassy EF, Wallace WD, Kallichanda NS, Behling CA, Miller DV, Oswal HN, Feddersen RM, Bakhtar OR, Mendoza AE, Molden DP, Saffer HL, Wixom CR, Albro JE, Cessna MH, Hall BJ, Lloyd IE, Bishop JW, Darrow MA, Gui D, Jen KY, Walby JAS, Bauer SM, Cortez DA, Gandhi P, Rodgers MM, Rodriguez RA, Martin DR, McConnell TG, Reynolds SJ, Spigel JH, Stepenaskie SA, Viktorova E, Magari R, Wharton KA, Qiu J, Bauer TW (2020). Digital Whole Slide Imaging Compared With Light Microscopy for Primary Diagnosis in Surgical Pathology. Arch Pathol Lab Med, 144(10), 1245-1253. (Read full article)
    5. Bauer TW, Behling C, Miller DV, Chang BS, Viktorova E, Magari R, Jensen PE, Wharton KA Jr, Qiu J (2020). Precise Identification of Cell and Tissue Features Important for Histopathologic Diagnosis by a Whole Slide Imaging System. J Pathol Inform, 11, 3. (Read full article)
    6. Taber DJ, Chokkalingam A, Su Z, Self S, Miller D, Srinivas T (2019). Randomized controlled trial assessing the impact of everolimus and low-exposure tacrolimus on graft outcomes in kidney transplant recipients. Clin Transplant, 33(10), e13679. (Read full article)
    7. Colvin MM, Cook JL, Chang PP, Hsu DT, Kiernan MS, Kobashigawa JA, Lindenfeld J, Masri SC, Miller DV, Rodriguez ER, Tyan DB, Zeevi A, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology Council on Cardiovascular Disease in the Young Council on Cardiovascular and Stroke Nursing and Council on Cardiovascular Surgery and Anesthesia (2019). Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association. Circulation, 139(12), e553-e578. (Read full article)
    8. Daud A, Xu D, Revelo MP, Shah Z, Drakos SG, Dranow E, Stoddard G, Kfoury AG, Hammond MEH, Nativi-Nicolau J, Alharethi R, Miller DV, Gilbert EM, Wever-Pinzon O, McKellar SH, Afshar K, Khan F, Fang JC, Selzman CH, Stehlik J (2018). Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy. Circ Heart Fail, 11(8), e004759. (Read full article)
    9. Chanana N, Van Dorn CS, Everitt MD, Weng HY, Miller DV, Menon SC (2017). Alteration of Cardiac Deformation in Acute Rejection in Pediatric Heart Transplant Recipients. Pediatr Cardiol, 38(4), 691-699. (Read full article)
    10. Bruneval P, Angelini A, Miller D, Potena L, Loupy A, Zeevi A, Reed EF, Dragun D, Reinsmoen N, Smith RN, West L, Tebutt S, Thum T, Haas M, Mengel M, Revelo P, Fedrigo M, Duong Van Huyen JP, Berry GJ (2016). The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions. Am J Transplant, 17(1), 42-53. (Read full article)
    11. Kim HS, Umbricht CB, Illei PB, Cimino-Mathews A, Cho S, Chowdhury N, Figueroa-Magalhaes MC, Pesce C, Jeter SC, Mylander C, Rosman M, Tafra L, Turner BM, Hicks DG, Jensen TA, Miller DV, Armstrong DK, Connolly RM, Fetting JH, Miller RS, Park BH, Stearns V, Visvanathan K, Wolff AC, Cope L (2016). Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer. J Clin Oncol, 34(36), 4390-4397. (Read full article)
    12. Lloyd IE, Gallan A, Huston HK, Raphael KL, Miller DV, Revelo MP, Khalighi MA (2016). C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome. Clin Kidney J, 9(6), 794-799. (Read full article)
    13. Diakos NA, Navankasattusas S, Abel ED, Rutter J, McCreath L, Ferrin P, McKellar SH, Miller DV, Park SY, Richardson RS, Deberardinis R, Cox JE, Kfoury AG, Selzman CH, Stehlik J, Fang JC, Li DY, Drakos SG (2016). Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning. JACC Basic Transl Sci, 1(6), 432-444. (Read full article)
    14. Ware AL, Miller DV, Erickson LK, Menon SC (2016). Marfan syndrome associated aortic disease in neonates and children: a clinical-morphologic review. Cardiovasc Pathol, 25(5), 418-22. (Read full article)
    15. Ko BS, Drakos S, Kfoury AG, Hurst D, Stoddard GJ, Willis CA, Delgado JC, Hammond EH, Gilbert EM, Alharethi R, Revelo MP, Nativi-Nicolau J, Reid BB, McKellar SH, Wever-Pinzon O, Miller DV, Eckels DD, Fang JC, Selzman CH, Stehlik J, Utah Transplant Affiliated Hospitals UTAH Cardiac Transplant Program (2016). Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. J Heart Lung Transplant, 35(8), 1024-30. (Read full article)
    16. Kfoury AG, Miller DV, Snow GL, Afshar K, Stehlik J, Drakos SG, Budge D, Fang JC, Revelo MP, Alharethi RA, Gilbert EM, Caine WT, McKellar S, Molina KM, Hammond MEH (2015). Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations. J Heart Lung Transplant, 35(3), 335-341. (Read full article)
    17. Hammond MEH, Revelo MP, Miller DV, Snow GL, Budge D, Stehlik J, Molina KM, Selzman CH, Drakos SG, Rami A A, Nativi-Nicolau JN, Reid BB, Kfoury AG (2015). ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis. J Heart Lung Transplant, 35(3), 320-325. (Read full article)
    18. Ware AL, Malmberg E, Delgado JC, Hammond ME, Miller DV, Stehlik J, Kfoury A, Revelo MP, Eckhauser A, Everitt MD (2015). The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children. J Heart Lung Transplant, 35(2), 179-85. (Read full article)
    19. Evans AC, Wright GA, McCandless SP, Stoker S, Miller D, Reid BB, Horne BD, Afshar K, Kfoury AG (2015). Ultraviolet Radiation Affects Thoratec HeartMate II Driveline Mechanical Properties: A Pilot Experiment. ASAIO J, 61(6), 731-3. (Read full article)
    20. Colvin MM, Cook JL, Chang P, Francis G, Hsu DT, Kiernan MS, Kobashigawa JA, Lindenfeld J, Masri SC, Miller D, OConnell J, Rodriguez ER, Rosengard B, Self S, White-Williams C, Zeevi A, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiopulmonary Critical Care Perioperative and Resuscitation, American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiovascular Disease in the Young, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology Council on Cardiovascular and Stroke Nursing, American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiovascular Radiology and Intervention, American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiovascular Surgery and Anesthesia (2015). Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association. Circulation, 131(18), 1608-39. (Read full article)
    21. Salvarani C, Brown RD Jr, Christianson T, Miller DV, Giannini C, Huston J 3rd, Hunder GG (2015). An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients. Medicine (Baltimore), 94(21), e738. (Read full article)

    Review

    1. Kfoury AG, Miller DV (2019). The impact of asymptomatic antibody-mediated rejection on outcome after heart transplantation. [Review]. Curr Opin Organ Transplant, 24(3), 259-264. (Read full article)
    2. Floyd A, Lal A, Molina K, Puchalski M, Miller D, May L (2018). When Lightning Strikes Twice in Pediatrics: Case Report and Review of Recurrent Myocarditis. [Review]. Pediatrics, 141(3). (Read full article)
    3. Halushka MK, Angelini A, Bartoloni G, Basso C, Batoroeva L, Bruneval P, Buja LM, Butany J, dAmati G, Fallon JT, Gallagher PJ, Gittenberger-de Groot AC, Gouveia RH, Kholova I, Kelly KL, Leone O, Litovsky SH, Maleszewski JJ, Miller DV, Mitchell RN, Preston SD, Pucci A, Radio SJ, Rodriguez ER, Sheppard MN, Stone JR, Suvarna SK, Tan CD, Thiene G, Veinot JP, van der Wal AC (2016). Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association For European Cardiovascular Pathology: II. Noninflammatory degenerative diseases - nomenclature and diagnostic criteria. [Review]. Cardiovasc Pathol, 25(3), 247-257. (Read full article)
    4. Stone JR, Bruneval P, Angelini A, Bartoloni G, Basso C, Batoroeva L, Buja LM, Butany J, dAmati G, Fallon JT, Gittenberger-de Groot AC, Gouveia RH, Halushka MK, Kelly KL, Kholova I, Leone O, Litovsky SH, Maleszewski JJ, Miller DV, Mitchell RN, Preston SD, Pucci A, Radio SJ, Rodriguez ER, Sheppard MN, Suvarna SK, Tan CD, Thiene G, van der Wal AC, Veinot JP (2015). Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. [Review]. Cardiovasc Pathol, 24(5), 267-78. (Read full article)

    Conference Proceedings

    1. Berry GJ, Angelini A, Burke MM, Bruneval P, Fishbein MC, Hammond E, Miller D, Neil D, Revelo MP, Rodriguez ER, Stewart S, Tan CD, Winters GL, Kobashigawa J, Mehra MR (2011). The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant, United States, 30(6), 601-11. (Read full article)